Science & Innovation Forum - Emerging Therapies for Sickle Cell Disease

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Friday, September 22, 2023 - On-Demand Available

Presented by QuidelOrtho

QuidelOrthoJoin us in recognition of National Sickle Cell Awareness Month as Dr. Titilope Fasipe, Co-Director of the Sickle Cell & Thalassemia Program at Texas Children’s Cancer & Hematology Center, discusses her lived experiences as a Sickle Cell Warrior, challenges associated with treating patients with SCD, and the research landscape of emerging therapies for the disease including promising gene and cellular therapies.

After attending this program, participants should be able to:

  • Discuss current and emerging treatments for sickle cell disease (SCD).
  • Describe the outlook for bringing new SCD therapies to market.
  • Advocate for sickle cell patients in the healthcare environment.
  • Registration

    This Science & Innovation Forum is complimentary to all, but registration is required. By registering for this AABB-hosted program you consent to have your information shared with the program sponsor, QuidelOrtho. Register here.


    Jeff WrenModerator: Jeff Wren, Vice President, Biotherapies, AABB

    Titilope Fasipe, MD, PhDSpeaker: Titilope Fasipe, MD, PhD, Co-Director, Sickle Cell & Thalassemia Program, Texas Children’s Cancer & Hematology Center, Assistant Professor, Department of Pediatrics, Baylor College of Medicine/Texas Children’s Hospital

    The content of this event was developed independently from the AABB continuing education program. The opinions expressed are those of the faculty. Continuing education credit is not offered.

    Science & Innovation Forums are live and on-demand programs that are presented by companies serving the AABB community and target critical needs in the field that can be addressed by the sponsor’s solutions technology. Registration is complimentary to all.